LEADER 03878nam 2200697Ia 450 001 9910956696503321 005 20200520144314.0 010 $a9786611321697 010 $a9781281321695 010 $a1281321699 010 $a9780470760154 010 $a047076015X 010 $a9780470759882 010 $a0470759887 035 $a(CKB)1000000000415500 035 $a(EBL)351355 035 $a(OCoLC)781319108 035 $a(SSID)ssj0000224618 035 $a(PQKBManifestationID)11210505 035 $a(PQKBTitleCode)TC0000224618 035 $a(PQKBWorkID)10210796 035 $a(PQKB)10243307 035 $a(MiAaPQ)EBC351355 035 $a(Au-PeEL)EBL351355 035 $a(CaPaEBR)ebr10232799 035 $a(CaONFJC)MIL132169 035 $a(Perlego)2773594 035 $a(EXLCZ)991000000000415500 100 $a20000823d2001 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aPortal hypertension III $eproceedings of the Third Baverno International Consensus Workshop on Definitions, Methodology, and Therapeutic Strategies /$fedited by Roberto De Franchis 205 $a3rd ed. 210 $aOxford ;$aMalden, MA $cBlackwell Science$d2001 215 $a1 online resource (270 p.) 300 $aDescription based upon print version of record. 311 08$a9780632059188 311 08$a0632059184 320 $aIncludes bibliographical references and index. 327 $aPortal Hypertension III; Contents; Contributors; Preface; Lecture What Have We Accomplished?; Session 1 Definition of Key Events: Let's Try Again; BAVENO III CONSENSUS STATEMENTS; Lecture Stellate Cells: Do They Have a Role in Portal Hypertension?; Session 2 Diagnosis of Portal Hypertension: How and When; BAVENO III CONSENSUS STATEMENTS; Session 3A Portal Hypertensive Gastropathy; Session 3B Gastric Varices; BAVENO III CONSENSUS STATEMENTS; Session 4 Preprimary Prophylaxis. Can (and Should) We Prevent the Formation and Growth of Varices; BAVENO III CONSENSUS STATEMENTS 327 $aLecture Antifibrotic Therapy: Future Cure for Portal Hypertension?Session 5 Primary Prophylaxis; BAVENO III CONSENSUS STATEMENTS; Session 6 Treatment of the Acute Bleeding Episode; BAVENO III CONSENSUS STATEMENTS; Session 7 Prevention of Recurrent Variceal Haemorrhage (Secondary Prophylaxis); BAVENO III CONSENSUS STATEMENTS; Session 8 Complications in the Medical Treatment of Portal Hypertension; BAVENO III CONSENSUS STATEMENTS; Lecture Quality of Randomized Clinical Trials in Portal Hypertension and Other Fields of Hepatology 327 $aSession 9 Methodology of Future Trials: Prognostic Stratification, Health-Related Quality of Life and Health EconomicsBAVENO III CONSENSUS STATEMENTS; Index 330 $aProceedings of the Third Baveno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies. The participants attempted to develop consensus definitions of key events in portal hypertension and variceal bleeding, diagnostic and therapeutic issues, and the complications of therapies for portal hypertension, as well as producing updated guidelines. The lectures summarized the consensus reached in the earlier workshops, addressed two important new areas of research, and analyzed the quality of trials in portal hypertension and other fields of hepatology. 517 3 $aPortal hypertension 3 517 3 $aPortal hypertension three 606 $aPortal hypertension$vCongresses 606 $aHypertension$vCongresses 615 0$aPortal hypertension 615 0$aHypertension 676 $a616.3/62 701 $aDe Franchis$b Roberto$0855338 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910956696503321 996 $aPortal hypertension III$92139944 997 $aUNINA